Tasmar behandlingen bør seponeres, hvis ALAT (alaninaminotransferase) og/ eller ASAT (aspartataminotransferase) overskrider den øvre referencegrænse, eller hvis der kommer symptomer eller tegn på start af leversvigt (Se 4. 4).
Tasmar treatment should also be discontinued if ALT (alanine amino transferase) and/ or AST (aspartate amino transferase) exceed the upper limit of normal or symptoms or signs suggest the onset of hepatic failure (see 4.4).